Contrast-enhanced Ultrasound-State of the Art in North America: Society of Radiologists in Ultrasound White Paper.
Journal
Ultrasound quarterly
ISSN: 1536-0253
Titre abrégé: Ultrasound Q
Pays: United States
ID NLM: 8809459
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
pubmed:
22
9
2020
medline:
14
9
2021
entrez:
21
9
2020
Statut:
ppublish
Résumé
On October 24, 2017, in Chicago, the Society of Radiologists in Ultrasound convened a panel of specialists in contrast-enhanced ultrasound (CEUS) to arrive at a white paper regarding the use of CEUS in noncardiac applications in North America. Recommendations are based on analysis of the current literature and common practice strategies. They represent a reasonable approach to introduce the advantages of this safe and noninvasive technique for the benefit of our patients. Characterization of liver nodules with CEUS, as the approval indication worldwide, is the major focus of this endeavor. In addition, many off label uses are reviewed and literature supporting these indications provided.Key Points(1) Contrast-enhanced ultrasound (CEUS) allows cross-sectional imaging of the liver, kidneys and multiple other solid and hollow viscera, providing excellent characterization of identified focal mass lesions.(2) Performed with the injection of a microbubble contrast agent, CEUS provides a safe and readily available imaging technique which requires no ionizing radiation, making it appropriate for use in all ages, in those with renal insufficiency and when a portable examination is needed.(3) The CEUS can be considered in abdominal imaging whenever blood flow information is of value to diagnosis.(4) Dynamic real-time acquisition and the use of a purely intravascular contrast agent are the 2 most essential technical aspects of CEUS imaging which distinguish it from both computed tomography and magnetic resonance scan.
Identifiants
pubmed: 32956244
doi: 10.1097/RUQ.0000000000000515
pii: 00013644-202009001-00001
doi:
Substances chimiques
Contrast Media
0
Types de publication
Journal Article
Practice Guideline
Langues
eng
Sous-ensembles de citation
IM
Pagination
S1-S39Références
Claudon M, Dietrich CF, Choi BI, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver—update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med. 2013;34(1):11–29.
Claudon M, Dietrich CF, Choi BI, et al., World Federation for Ultrasound in Medicine; European Federation of Societies for Ultrasound. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver—update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol. 2013;39(2):187–210.
Piscaglia F, Nolsøe C, Dietrich CF, et al. The EFSUMB guidelines and recommendations on the clinical practice of contrast enhanced ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med. 2012;33(1):33–59.
Barr RG. Off-label use of ultrasound contrast agents for abdominal imaging in the United States. J Ultrasound Med. 2013;32(1):7–12.
Wilson SR, Kim TK, Jang HJ, et al. Enhancement patterns of focal liver masses: discordance between contrast-enhanced sonography and contrast-enhanced CT and MRI. AJR Am J Roentgenol. 2007;189(1):W7–W12.
Averkiou MA, Mannarisa C, Bruce M, et al. Nonlinear pulsing schemes for the detection of ultrasound contrast agents, in Acoustics ‘08. 2008. Paris, France.
AIUM. https://www.aium.org/resources/viewStatement.aspx?id=47 2019.
Sparchez Z, Radu P, Sparchez M, et al. Contrast enhanced ultrasound of renal masses. A reappraisal of EFSUMB recommendations and possible emerging applications. Med Ultrason. 2015;17(2):219–226.
Dietrich CF, Averkiou MA, Correas JM, et al. An EFSUMB introduction into dynamic contrast-enhanced ultrasound (DCE-US) for quantification of tumour perfusion. Ultraschall Med. 2012;33(4):344–351.
Nolsøe CP, Lorentzen T. International guidelines for contrast-enhanced ultrasonography: ultrasound imaging in the new millennium. Ultrasonography. 2016;35(2):89–103.
Sidhu PS, Cantisani V, Dietrich CF, et al. The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (long version). Ultraschall Med. 2018;39(2):e2–e44.
Media A.C.o.D.a.C. ACR Manual on Contrast Media. American College of Radiology; 2017:93–95.
Piscaglia F, Bolondi L; Italian Society for Ultrasound in Medicine and Biology (SIUMB) Study Group on Ultrasound Contrast Agents. The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol. 2006;32(9):1369–1375.
Darge K, Papadopoulou F, Ntoulia A, et al. Safety of contrast-enhanced ultrasound in children for non-cardiac applications: a review by the Society for Pediatric Radiology (SPR) and the International Contrast Ultrasound Society (ICUS). Pediatr Radiol. 2013;43(9):1063–1073.
Wever-Pinzon O, Suma V, Ahuja A, et al. Safety of echocardiographic contrast in hospitalized patients with pulmonary hypertension: a multi-center study. Eur Heart J Cardiovasc Imaging. 2012;13(10):857–862.
Schwarze V, Marschner C, Negrão de Figueiredo G, et al. Single-center study: evaluating the diagnostic performance and safety of contrast-enhanced ultrasound (CEUS) in pregnant women to assess hepatic lesions. Ultraschall Med. 2020;41(1):29–35.
Windrim R, Kingdom J, Jang HJ, et al. Contrast enhanced ultrasound (CEUS) in the prenatal evaluation of suspected invasive placenta percreta. J Obstet Gynaecol Can. 2016;38(10):975–978.
US Food and Drug Administration. “Off-label” and investigational use of marketed drugs, biologics, and medical devices: information sheet. US Food and Drug Administration website; 2011.
Guang Y, Xie L, Ding H, et al. Diagnosis value of focal liver lesions with SonoVue®-enhanced ultrasound compared with contrast-enhanced computed tomography and contrast-enhanced MRI: a meta-analysis. J Cancer Res Clin Oncol. 2011;137(11):1595–1605.
Wilson SR, Burns PN. An algorithm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion sonography. AJR Am J Roentgenol. 2006;186(5):1401–1412.
Burns PN, Wilson SR. Focal liver masses: enhancement patterns on contrast-enhanced images—concordance of US scans with CT scans and MR images. Radiology. 2007;242(1):162–174.
Hu J, Bhayana D, Burak KW, et al. Resolution of indeterminate MRI with CEUS in patients at high risk for hepatocellular carcinoma. Abdom Radiol (NY). 2020;45(1):123–133.
Lyshchik A, Kono Y, Dietrich CF, et al. Contrast-enhanced ultrasound of the liver: technical and lexicon recommendations from the ACR CEUS LI-RADS working group. Abdom Radiol (NY). 2018;43(4):861–879.
Burrowes DP, Medellin A, Harris AC, et al. Contrast-enhanced US approach to the diagnosis of focal liver masses. Radiographics. 2017;37(5):1388–1400.
Jang HJ, Kim TK, Wilson SR. Small nodules (1-2 cm) in liver cirrhosis: characterization with contrast-enhanced ultrasound. Eur J Radiol. 2009;72(3):418–424.
Durot I, Wilson SR, Willmann JK. Contrast-enhanced ultrasound of malignant liver lesions. Abdom Radiol (NY). 2018;43(4):819–847.
Yang HK, Burns PN, Jang HJ, et al. Contrast-enhanced ultrasound approach to the diagnosis of focal liver lesions: the importance of washout. Ultrasonography. 2019;38(4):289–301.
Jang HJ, Kim TK, Burns PN, et al. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology. 2007;244(3):898–906.
Jo PC, Jang HJ, Burns PN, et al. Integration of contrast-enhanced US into a multimodality approach to imaging of nodules in a cirrhotic liver: how I do it. Radiology. 2017;282(2):317–331.
Kim H, Park YN. Focal nodular hyperplasia-like nodule in liver cirrhosis. Korean J Hepatol. 2008;14(2):226–230.
Dietrich CF, Tannapfel A, Jang HJ, et al. Ultrasound imaging of hepatocellular adenoma using the new histology classification. Ultrasound Med Biol. 2019;45(1):1–10.
Albrecht T, Blomley MJK, Burns PN, et al. Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology. 2003;227(2):361–370.
Wilson SR, Lyshchik A, Piscaglia F, et al. CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI. Abdom Radiol (NY). 2018;43(1):127–142.
available from www.acr.org/Quality-Safety/Resources/LIRADS.
Matsui O, Gabata T, Kobayashi S, et al. Imaging of multistep human hepatocarcinogenesis. Hepatol Res. 2007;37(Suppl 2):S200–S205.
Terzi E, Iavarone M, Pompili M, et al. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter retrospective study of 1,006 nodules. J Hepatol. 2018;68(3):485–492.
Makoyeva A, Kim TK, Jang HJ, et al. Use of CEUS LI-RADS for the accurate diagnosis of nodules in patients at risk for hepatocellular carcinoma: a validation study. Imaging Cancer. 2020;2: p. in press.
Silverman SG, Pedrosa I, Ellis JH, et al. Bosniak classification of cystic renal masses, version 2019: an update proposal and needs assessment. Radiology. 2019;292(2):475–488.
Chung EP, Herts BR, Linnell G, et al. Analysis of changes in attenuation of proven renal cysts on different scanning phases of triphasic MDCT. AJR Am J Roentgenol. 2004;182(2):405–410.
Hartman DS, Weatherby E 3rd, Laskin WB, et al. Cystic renal cell carcinoma: CT findings simulating a benign hyperdense cyst. AJR Am J Roentgenol. 1992;159(6):1235–1237.
Spaliviero M, Herts BR, Magi-Galluzzi C, et al. Laparoscopic partial nephrectomy for cystic masses. J Urol. 2005;174(2):614–619.
Siegel CL, McFarland EG, Brink JA, et al. CT of cystic renal masses: analysis of diagnostic performance and interobserver variation. AJR Am J Roentgenol. 1997;169(3):813–818.
Ascenti G, Mazziotti S, Zimbaro G, et al. Complex cystic renal masses: characterization with contrast-enhanced US. Radiology. 2007;243(1):158–165.
Clevert DA, Minaifar N, Weckbach S, et al. Multislice computed tomography versus contrast-enhanced ultrasound in evaluation of complex cystic renal masses using the Bosniak classification system. Clin Hemorheol Microcirc. 2008;39(1–4):171–178.
Correas JM, Claudon M, Tranquart F, et al. The kidney: imaging with microbubble contrast agents. Ultrasound Q. 2006;22(1):53–66.
Ignee A, Straub B, Brix D, et al. The value of contrast enhanced ultrasound (CEUS) in the characterisation of patients with renal masses. Clin Hemorheol Microcirc. 2010;46(4):275–290.
Mazziotti S, Zimbaro F, Pandolfo A, et al. Usefulness of contrast-enhanced ultrasonography in the diagnosis of renal pseudotumors. Abdom Imaging. 2010;35(2):241–245.
Park BK, Kim B, Kim SH, et al. Assessment of cystic renal masses based on Bosniak classification: comparison of CT and contrast-enhanced US. Eur J Radiol. 2007;61(2):310–314.
Quaia E, Bertolotto M, Cioffi V, et al. Comparison of contrast-enhanced sonography with unenhanced sonography and contrast-enhanced CT in the diagnosis of malignancy in complex cystic renal masses. AJR Am J Roentgenol. 2008;191(4):1239–1249.
Robbin ML, Lockhart ME, Barr RG. Renal imaging with ultrasound contrast: current status. Radiol Clin North Am. 2003;41(5):963–978.
Sanchez K, Barr RG. Contrast-enhanced ultrasound detection and treatment guidance in a renal transplant patient with renal cell carcinoma. Ultrasound Q. 2009;25(4):171–173.
Tamai H, Takiguchi Y, Oka M, et al. Contrast-enhanced ultrasonography in the diagnosis of solid renal tumors. J Ultrasound Med. 2005;24(12):1635–1640.
Barr RG, Peterson C, Hindi A. Evaluation of indeterminate renal masses with contrast-enhanced US: a diagnostic performance study. Radiology. 2014;271(1):133–142.
Zarzour JG, Lockhart ME, West J, et al. Contrast-enhanced ultrasound classification of previously indeterminate renal lesions. J Ultrasound Med. 2017;36(9):1819–1827.
Tomich J, Grove Nigro K, Barr RG. Primary angiosarcoma of the breast: a case report and review of the literature. Ultrasound Q. 2017;33(1):46–48.
Kim JK, Kim TK, Ahn HJ, et al. Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR Am J Roentgenol. 2002;178(6):1499–1506.
Low G, Huang G, Fu W, et al. Review of renal cell carcinoma and its common subtypes in radiology. World J Radiol. 2016;8(5):484–500.
Egbert ND, Caoili EM, Cohan RH, et al. Differentiation of papillary renal cell carcinoma subtypes on CT and MRI. AJR Am J Roentgenol. 2013;201(2):347–355.
Sun MR, Ngo L, Genega EM, et al. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes–correlation with pathologic findings. Radiology. 2009;250(3):793–802.
Hötker AM, Mazaheri Y, Wibmer A, et al. Differentiation of clear cell renal cell carcinoma from other renal cortical tumors by use of a quantitative multiparametric MRI approach. AJR Am J Roentgenol. 2017;208(3):W85–W91.
Xue LY, Lu Q, Huang BJ, et al. Differentiation of subtypes of renal cell carcinoma with contrast-enhanced ultrasonography. Clin Hemorheol Microcirc. 2016;63(4):361–371.
Sun D, Wei C, Li Y, et al. Contrast-enhanced ultrasonography with quantitative analysis allows differentiation of renal tumor histotypes. Sci Rep. 2016;6:35081.
Fetzer DT, Rafailidis V, Peterson C, et al. Artifacts in contrast-enhanced ultrasound: a pictorial essay. Abdom Radiol (NY). 2018;43(4):977–997.
Koutroubakis IE, Tsiolakidou G, Karmiris K, et al. Role of angiogenesis in inflammatory bowel disease. Inflamm Bowel Dis. 2006;12(6):515–523.
Danese S, Sans M, de la Motte C, et al. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology. 2006;130(7):2060–2073.
De Franco A, Di Veronica A, Armuzzi A, et al. Ileal Crohn disease: mural microvascularity quantified with contrast-enhanced US correlates with disease activity. Radiology. 2012;262(2):680–688.
Wilkens R, Pournazari P, Wilosn S. CEUS of the Bowel in Inflammatory Bowel Disease, in Contrast-Enhanced Ultrasound. London: International MEdical Publishers; 2013:222–229.
Greis C. Quantitative evaluation of microvascular blood flow by contrast-enhanced ultrasound (CEUS). Clin Hemorheol Microcirc. 2011;49(1–4):137–149.
VueBoxTM quantification toolbox instructions for use. 2017; Available from: http://www.contrastultrasound-modality.com/sites/default/files/cpn/images/pdf/2016-11-01-4-2-VueBox-EN-Instructions-for-use.pdf.
Ripollés T, Martínez MJ, Paredes JM, et al. Crohn disease: correlation of findings at contrast-enhanced US with severity at endoscopy. Radiology. 2009;253(1):241–248.
Migaleddu V, Quaia E, Scanu D, et al. Inflammatory activity in Crohn's disease: CE-US. Abdom Imaging. 2011;36(2):142–148.
Quaia E, Sozzi M, Angileri R, et al. Time-intensity curves obtained after microbubble injection can be used to differentiate responders from nonresponders among patients with clinically active Crohn disease after 6 weeks of pharmacologic treatment. Radiology. 2016;281(2):606–616.
Lu C, Gui X, Chen W, et al. Ultrasound shear wave elastography and contrast enhancement: effective biomarkers in Crohn's disease strictures. Inflamm Bowel Dis. 2017;23(3):421–430.
Schirin-Sokhan R, Winograd R, Tischendorf S, et al. Assessment of inflammatory and fibrotic stenoses in patients with Crohn's disease using contrast-enhanced ultrasound and computerized algorithm: a pilot study. Digestion. 2011;83(4):263–268.
Medellin-Kowalewski A, Wilkens R, Wilson A, et al. Quantitative contrast-enhanced ultrasound parameters in Crohn disease: their role in disease activity determination with ultrasound. AJR Am J Roentgenol. 2016;206(1):64–73.
Ripollés T, Martínez-Pérez MJ, Paredes JM, et al. Contrast-enhanced ultrasound in the differentiation between phlegmon and abscess in Crohn's disease and other abdominal conditions. Eur J Radiol. 2013;82(10):e525–e531.
Omar A, Freeman S. Contrast-enhanced ultrasound of the spleen. Ultrasound. 2016;24(1):41–49.
D'Onofrio M, Canestrini S, De Robertis R, et al. CEUS of the pancreas: still research or the standard of care. Eur J Radiol. 2015;84(9):1644–1649.
D'Onofrio M, Gallotti A, Principe F, et al. Contrast-enhanced ultrasound of the pancreas. World J Radiol. 2010;2(3):97–102.
Qiao JJ, Yu J, Yu Z, et al. Contrast-enhanced ultrasonography in differential diagnosis of benign and malignant ovarian tumors. PLoS One. 2015;10(3):e0118872.
Fleischer AC, Lyshchik A, Jones HW Jr., et al. Contrast-enhanced transvaginal sonography of benign versus malignant ovarian masses: preliminary findings. J Ultrasound Med. 2008;27(7):1011–1018; quiz 1019-21.
Marret H, Sauget S, Giraudeau B, et al. Contrast-enhanced sonography helps in discrimination of benign from malignant adnexal masses. J Ultrasound Med. 2004;23(12):1629–1639; quiz 1641-42.
Testa AC, Timmerman D, van Belle V, et al. Intravenous contrast ultrasound examination using contrast-tuned imaging (CnTI) and the contrast medium SonoVue for discrimination between benign and malignant adnexal masses with solid components. Ultrasound Obstet Gynecol. 2009;34(6):699–710.
Veyer L, Marret H, Bleuzen A, et al. Preoperative diagnosis of ovarian tumors using pelvic contrast-enhanced sonography. J Ultrasound Med. 2010;29(7):1041–1049.
Liu Z, Yang F, Zhang Y, et al. Conventional, Doppler and contrast-enhanced ultrasonography in differential diagnosis of ovarian masses. Cell Physiol Biochem. 2016;39(6):2398–2408.
Sconfienza LM, Perrone N, Delnevo A, et al. Diagnostic value of contrast-enhanced ultrasonography in the characterization of ovarian tumors(). J Ultrasound. 2010;13(1):9–15.
Isidori AM, Pozza C, Gianfrilli D, et al. Differential diagnosis of nonpalpable testicular lesions: qualitative and quantitative contrast-enhanced US of benign and malignant testicular tumors. Radiology. 2014;273(2):606–618.
Lock G, Schmidt C, Schröder C, et al. Straight vessel pattern and rapid filling time: characteristic findings on contrast-enhanced sonography of testicular lymphoma. J Ultrasound Med. 2016;35(7):1593–1599.
Shah A, Lung PF, Clarke JL, et al. Re: new ultrasound techniques for imaging of the indeterminate testicular lesion may avoid surgery completely. Clin Radiol. 2010;65(6):496–497.
Auer T, de Zordo T, Dejaco C, et al. Value of multiparametric US in the assessment of intratesticular lesions. Radiology. 2017;285(2):640–649.
De Zordo T, Stronegger D, Pallwein-Prettner L, et al. Multiparametric ultrasonography of the testicles. Nat Rev Urol. 2013;10(3):135–148.
Kachramanoglou C, Rafailidis V, Philippidou M, et al. Multiparametric sonography of hematologic malignancies of the testis: grayscale, color Doppler, and contrast-enhanced ultrasound and strain elastographic appearances with histologic correlation. J Ultrasound Med. 2017;36(2):409–420.
Patel K, Sellars ME, Clarke JL, et al. Features of testicular epidermoid cysts on contrast-enhanced sonography and real-time tissue elastography. J Ultrasound Med. 2012;31(1):115–122.
Bertolotto M, Derchi LE, Sidhu PS, et al. Acute segmental testicular infarction at contrast-enhanced ultrasound: early features and changes during follow-up. AJR Am J Roentgenol. 2011;196(4):834–841.
Moschouris H, Stamatiou K, Lampropoulou E, et al. Imaging of the acute scrotum: is there a place for contrast-enhanced ultrasonography?Int Braz J Urol. 2009;35(6):692–702; discussion 702-5.
Valentino M, Bertolotto M, Derchi L, et al. Role of contrast enhanced ultrasound in acute scrotal diseases. Eur Radiol. 2011;21(9):1831–1840.
Paltiel HJ, Padua HM, Gargollo PC, et al. Contrast-enhanced, real-time volumetric ultrasound imaging of tissue perfusion: preliminary results in a rabbit model of testicular torsion. Phys Med Biol. 2011;56(7):2183–2197.
Lobianco R, Regine R, de Siero M, et al. Contrast-enhanced sonography in blunt scrotal trauma(). J Ultrasound. 2011;14(4):188–195.
Rafailidis V, Robbie H, Konstantatou E, et al. Sonographic imaging of extra-testicular focal lesions: comparison of grey-scale, colour Doppler and contrast-enhanced ultrasound. Ultrasound. 2016;24(1):23–33.
Lee SC, Tchelepi H, Grant E, et al. Contrast-enhanced ultrasound imaging of breast masses: adjunct tool to decrease the number of false-positive biopsy results. J Ultrasound Med. 2019;38(9):2259–2273.
Ricci P, Cantisani V, Ballesio L, et al. Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging. Ultraschall Med. 2007;28(1):57–62.
Xiao X, Ou B, Yang H, et al. Breast contrast-enhanced ultrasound: is a scoring system feasible? A preliminary study in China. PLoS One. 2014;9(8):e105517.
Smeenge M, Mischi M, Laguna Pes MP, et al. Novel contrast-enhanced ultrasound imaging in prostate cancer. World J Urol. 2011;29(5):581–587.
Strazdina A, Krumina G, Sperga M. The value and limitations of contrast-enhanced ultrasound in detection of prostate cancer. Anticancer Res. 2011;31(4):1421–1426.
Trabulsi EJ, Calio BP, Kamel SI, et al. Prostate contrast enhanced transrectal ultrasound evaluation of the prostate with whole-mount prostatectomy correlation. Urology. 2019;133:187–191.
Halpern EJ, Gomella LG, Forsberg F, et al. Contrast enhanced transrectal ultrasound for the detection of prostate cancer: a randomized, double-blind trial of dutasteride pretreatment. J Urol. 2012;188(5):1739–1745.
Yunkai Z, Yaqing C, Jun J, et al. Comparison of contrast-enhanced ultrasound targeted biopsy versus standard systematic biopsy for clinically significant prostate cancer detection: results of a prospective cohort study with 1024 patients. World J Urol. 2019;37(5):805–811.
Li Y, Tang J, Fei X, et al. Diagnostic performance of contrast enhanced ultrasound in patients with prostate cancer: a meta-analysis. Acad Radiol. 2013;20(2):156–164.
Apfelbeck M, Chaloupka M, Schlenker B, et al. Follow-up after focal therapy of the prostate with high intensity focused ultrasound (HIFU) using contrast enhanced ultrasound (CEUS) in combination with MRI image fusion. Clin Hemorheol Microcirc. 2019;73(1):135–143.
Moschouris H, Stamatiou K, Malagari K, et al. The value of contrast-enhanced ultrasonography in detection of prostatic infarction after prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia. Diagn Interv Radiol. 2019;25(2):134–143.
Maxeiner A, Fischer T, Schwabe J, et al. Contrast-enhanced ultrasound (CEUS) and quantitative perfusion analysis in patients with suspicion for prostate cancer. Ultraschall Med. 2019;40(3):340–348.
Kuenen MP, Saidov TA, Wijkstra H, et al. Spatiotemporal correlation of ultrasound contrast agent dilution curves for angiogenesis localization by dispersion imaging. IEEE Trans Ultrason Ferroelectr Freq Control. 2013;60(12):2665–2669.
van Sloun RJ, Demi L, Postema AW, et al. Ultrasound-contrast-agent dispersion and velocity imaging for prostate cancer localization. Med Image Anal. 2017;35:610–619.
Postema AW, Frinking PJA, Smeenge M, et al. Dynamic contrast-enhanced ultrasound parametric imaging for the detection of prostate cancer. BJU Int. 2016;117(4):598–603.
Schleder S, Janke M, Agha A, et al. Preoperative differentiation of thyroid adenomas and thyroid carcinomas using high resolution contrast-enhanced ultrasound (CEUS). Clin Hemorheol Microcirc. 2015;61(1):13–22.
Yuan Z, Quan J, Yunxiao Z, et al. Contrast-enhanced ultrasound in the diagnosis of solitary thyroid nodules. J Cancer Res Ther. 2015;11(1):41–45.
Adler RS, Fealy S, Rudzki JR, et al. Rotator cuff in asymptomatic volunteers: contrast-enhanced US depiction of intratendinous and peritendinous vascularity. Radiology. 2008;248(3):954–961.
Gamradt SC, Gallo RA, Adler RS, et al. Vascularity of the supraspinatus tendon three months after repair: characterization using contrast-enhanced ultrasound. J Shoulder Elbow Surg. 2010;19(1):73–80.
Rudzki JR, Adler RS, Warren RF, et al. Contrast-enhanced ultrasound characterization of the vascularity of the rotator cuff tendon: age- and activity-related changes in the intact asymptomatic rotator cuff. J Shoulder Elbow Surg. 2008;17(1 Suppl):96S–100S.
Cadet ER, Adler RS, Gallo RA, et al. Contrast-enhanced ultrasound characterization of the vascularity of the repaired rotator cuff tendon: short-term and intermediate-term follow-up. J Shoulder Elbow Surg. 2012;21(5):597–603.
Claudon M, Cosgrove D, Albrecht T, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)—update 2008. Ultraschall Med. 2008;29(1):28–44.
Sidhu PS, Cantisani V, Deganello A, et al. Role of contrast-enhanced ultrasound (CEUS) in paediatric practice: an EFSUMB position statement. Ultraschall Med. 2017;38(1):33–43.
Parodi JC, Palmaz JC, Barone HD. Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg. 1991;5(6):491–499.
Giles KA, Pomposelli F, Hamdan A, et al. Decrease in total aneurysm-related deaths in the era of endovascular aneurysm repair. J Vasc Surg. 2009;49(3):543–550; discussion 550-1.
Chaer RA. In: Mills JL, Eidt JF, Mohler Iii ER, eds. Endovascular Repair of Abdominal Aortic Aneurysm, in UpToDate. Waltham, MA: UpToDate Inc; 2017.
Chaer RA, Avgerinos E. In: Eidt JF, Mills JL, Collins KA, eds. Endoleak Following Endovascular Aortic Repair, in UpToDate. Waltham, MA: UpToDate Inc; 2017.
Chaikof EL, Brewster DC, Dalman RL, et al. SVS practice guidelines for the care of patients with an abdominal aortic aneurysm: executive summary. J Vasc Surg. 2009;50(4):880–896.
Ashoke R, Brown LC, Rodway A, et al. Color duplex ultrasonography is insensitive for the detection of endoleak after aortic endografting: a systematic review. J Endovasc Ther. 2005;12(3):297–305.
Zaiem F, Almasri J, Tello M, et al. A systematic review of surveillance after endovascular aortic repair. J Vasc Surg. 2018;67(1):320–331.e37.
Iezzi R, Basilico R, Giancristofaro D, et al. Contrast-enhanced ultrasound versus color duplex ultrasound imaging in the follow-up of patients after endovascular abdominal aortic aneurysm repair. J Vasc Surg. 2009;49(3):552–560.
Bendick PJ, Bove PG, Long GW, et al. Efficacy of ultrasound scan contrast agents in the noninvasive follow-up of aortic stent grafts. J Vasc Surg. 2003;37(2):381–385.
Mirza TA, Karthikesalingam A, Jackson D, et al. Duplex ultrasound and contrast-enhanced ultrasound versus computed tomography for the detection of endoleak after EVAR: systematic review and bivariate meta-analysis. Eur J Vasc Endovasc Surg. 2010;39(4):418–428.
Karthikesalingam A, Al-Jundi W, Jackson D, et al. Systematic review and meta-analysis of duplex ultrasonography, contrast-enhanced ultrasonography or computed tomography for surveillance after endovascular aneurysm repair. Br J Surg. 2012;99(11):1514–1523.
Sun C, Lin S, Zhao L, et al. A meta-analysis of ultrasound imaging in diagnosis of endoleak among patients after endovascular abdominal aortic aneurysm repair. Int J Clin Exp Med. 2017;10(1):1502–1512.
Guo Q, Zhao J, Huang B, et al. A systematic review of ultrasound or magnetic resonance imaging compared with computed tomography for endoleak detection and aneurysm diameter measurement after endovascular aneurysm repair. J Endovasc Ther. 2016;23(6):936–943.
Eisenbrey JR, Sridharan A, Liu JB, et al. Recent experiences and advances in contrast-enhanced subharmonic ultrasound. Biomed Res Int. 2015;2015:1–6.
Napoli V, Bargellini I, Sardella SG, et al. Abdominal aortic aneurysm: contrast-enhanced US for missed endoleaks after endoluminal repair. Radiology. 2004;233(1):217–225.
Carrafiello G, Laganà D, Recaldini C, et al. Comparison of contrast-enhanced ultrasound and computed tomography in classifying endoleaks after endovascular treatment of abdominal aorta aneurysms: preliminary experience. Cardiovasc Intervent Radiol. 2006;29(6):969–974.
Giannoni MF, Fanelli F, Citone M, et al. Contrast ultrasound imaging: the best method to detect type II endoleak during endovascular aneurysm repair follow-up☆. Interact Cardiovasc Thorac Surg. 2007;6(3):359–362.
David E, Cantisani V, Grazhdani H, et al. What is the role of contrast-enhanced ultrasound in the evaluation of the endoleak of aortic endoprostheses? A comparison between CEUS and CT on a widespread scale. J Ultrasound. 2016;19(4):281–287.
Bargellini I, Napoli V, Petruzzi P, et al. Type II lumbar endoleaks: hemodynamic differentiation by contrast-enhanced ultrasound scanning and influence on aneurysm enlargement after endovascular aneurysm repair. J Vasc Surg. 2005;41(1):10–18.
Blackwood S, Mix D, Chandra A, et al. A model to demonstrate that endotension is a nonvisualized type I endoleak. J Vasc Surg. 2016;64(3):779–787.
Lowe C, Abbas A, Rogers S, et al. Three-dimensional contrast-enhanced ultrasound improves endoleak detection and classification after endovascular aneurysm repair. J Vasc Surg. 2017;65(5):1453–1459.
Gargiulo M, Gallitto E, Serra C, et al. Could four-dimensional contrast-enhanced ultrasound replace computed tomography angiography during follow up of fenestrated endografts? Results of a preliminary experience. Eur J Vasc Endovasc Surg. 2014;48(5):536–542.
Birth M, Iblher P, Hildebrand P, et al. Ultrasound-guided interventions using magnetic field navigation. First experiences with ultra-guide 2000 under operative conditions. Ultraschall Med. 2003;24(2):90–95.
Solbiati L, Ierace T, Tonolini M, et al. Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. Eur J Radiol. 2004;51(Suppl):S19–S23.
Sparchez Z, Radu P, Zaharia T, et al. Usefulness of contrast enhanced ultrasound guidance in percutaneous biopsies of liver tumors. J Gastrointestin Liver Dis. 2011;20(2):191–196.
Wu W, Chen MH, Yan K, et al. Application of contrast-enhanced ultrasound to increase the diagnostic rate of liver tumor by biopsy. Zhonghua Yi Xue Za Zhi. 2006;86(2):116–120.
Francque SM, De Pauw FF, Van den Steen GH, et al. Biopsy of focal liver lesions: guidelines, comparison of techniques and cost-analysis. Acta Gastroenterol Belg. 2003;66(2):160–165.
Yoon SH, Lee KH, Kim SY, et al. Real-time contrast-enhanced ultrasound-guided biopsy of focal hepatic lesions not localised on B-mode ultrasound. Eur Radiol. 2010;20(8):2047–2056.
Cao BS, Wu JH, Li XL, et al. Sonographically guided transthoracic biopsy of peripheral lung and mediastinal lesions: Role of Contrast-Enhanced Sonography. J Ultrasound Med. 2011;30(11):1479–1490.
Wang S, Yang W, Zhang H, et al. The role of contrast-enhanced ultrasound in selection indication and improveing diagnosis for transthoracic biopsy in peripheral pulmonary and mediastinal lesions. Biomed Res Int. 2015;2015:231782.
Mao F, et al. Comparison of contrast-enhanced ultrasound and conventional ultrasound for guiding peripheral pulmonary biopsies. Int J Clin Exp Med. 2017;10(2):3677.
Madsen HHT, Rasmussen F. Contrast-enhanced ultrasound in oncology. Cancer Imaging. 2011;11(1A):S167–S173.
Postema AW, Scheltema MJ, Mannaerts CK, et al. The prostate cancer detection rates of CEUS-targeted versus MRI-targeted versus systematic TRUS-guided biopsies in biopsy-naïve men: a prospective, comparative clinical trial using the same patients. BMC Urol. 2017;17(1):27.
Boczko J, Messing E, Dogra V. Transrectal sonography in prostate evaluation. Radiol Clin North Am. 2006;44(5):679–687, viii.
Zhao HX, Xia CX, Yin HX, et al. The value and limitations of contrast-enhanced transrectal ultrasonography for the detection of prostate cancer. Eur J Radiol. 2013;82(11):e641–e647.
Taverna G, Morandi G, Seveso M, et al. Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling. BJU Int. 2011;108(11):1723–1727.
Mitterberger MJ, Aigner F, Horninger W, et al. Comparative efficiency of contrast-enhanced colour Doppler ultrasound targeted versus systematic biopsy for prostate cancer detection. Eur Radiol. 2010;20(12):2791–2796.
Linden RA, Trabulsi EJ, Forsberg F, et al. Contrast enhanced ultrasound flash replenishment method for directed prostate biopsies. J Urol. 2007;178(6):2354–2358.
Frauscher F, Klauser A, Volgger H, et al. Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol. 2002;167(4):1648–1652.
Schlottmann K, Klebl F, Zorger N, et al. Contrast-enhanced ultrasound allows for interventions of hepatic lesions which are invisible on convential B-mode. Z Gastroenterol. 2004;42(4):303–310.
Kang TW, Lee MW, Song KD, et al. Added value of contrast-enhanced ultrasound on biopsies of focal hepatic lesions invisible on fusion imaging guidance. Korean J Radiol. 2017;18(1):152–161.
Kono Y, Lucidarme O, Choi SH, et al. Contrast-enhanced ultrasound as a predictor of treatment efficacy within 2 weeks after transarterial chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol. 2007;18(1):57–65.
Shaw CM, Eisenbrey JR, Lyshchik A, et al. Contrast-enhanced ultrasound evaluation of residual blood flow to hepatocellular carcinoma after treatment with Transarterial chemoembolization using drug-eluting beads. J Ultrasound Med. 2015;34(5):859–867.
Hines-Peralta A, Goldberg SN. In: Ross ME, ed. Radiofrequency ablation and cryoablation of renal cell carcinoma, in UpToDate. Waltham, MA: UpToDate Inc; 2016.
Barwari K, Wijkstra H, van Delden OM, et al. Contrast-enhanced ultrasound for the evaluation of the cryolesion after laparoscopic renal cryoablation: an initial report. J Endourol. 2013;27(4):402–407.
Sanz E, Hevia V, Arias F, et al. Contrast-enhanced ultrasound (CEUS): an excellent tool in the follow-up of small renal masses treated with Cryoablation. Curr Urol Rep. 2015;16(1):469.
Eisenbrey JR, Shaw CM, Lyshchik A, et al. Contrast-enhanced subharmonic and harmonic ultrasound of renal masses undergoing percutaneous cryoablation. Acad Radiol. 2015;22(7):820–826.
Mauri G, Porazzi E, Cova L, et al. Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment. Insights Imaging. 2014;5(2):209–216.
Zhao X, Wang W, Zhang S, et al. Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: a retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients. Abdom Imaging. 2012;37(5):885–891.
Bansal S, Gui J, Merrill C, et al. Contrast-enhanced US in local ablative therapy and secondary surveillance for hepatocellular carcinoma. Radiographics. 2019;39(5):1302–1322.
Chen MH, Yang W, Yan K, et al. Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients—mathematic model, overlapping mode, and electrode placement process. Radiology. 2004;232(1):260–271.
Roccarina D, Garcovich M, Ainora ME, et al. Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatment. World J Hepatol. 2015;7(14):1866–1874.
Liu M, Lin MX, Lu MD, et al. Comparison of contrast-enhanced ultrasound and contrast-enhanced computed tomography in evaluating the treatment response to transcatheter arterial chemoembolization of hepatocellular carcinoma using modified RECIST. Eur Radiol. 2015;25(8):2502–2511.
Morimoto M, Shirato K, Sugimori K, et al. Contrast-enhanced harmonic gray-scale sonographic-histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. Am J Roentgenol. 2003;181(1):65–69.
Kim HJ, Kim TK, Kim PN, et al. Assessment of the therapeutic response of hepatocellular carcinoma treated with transcatheter arterial chemoembolization. J Ultrasound Med. 2006;25(4):477–486.
Minami Y, Kudo M, Kawasaki T, et al. Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography. Am J Roentgenol. 2003;180(3):703–708.
Darge K. Voiding urosonography with ultrasound contrast agents for the diagnosis of vesicoureteric reflux in children. I. Procedure. Pediatr Radiol. 2008;38(1):40–53.
Darge K. Voiding urosonography with US contrast agents for the diagnosis of vesicoureteric reflux in children. II. Comparison with radiological examinations. Pediatr Radiol. 2008;38(1):54–63; quiz 126-7.
Yusuf GT, Sellars ME, Deganello A, et al. Retrospective analysis of the safety and cost implications of pediatric contrast-enhanced ultrasound at a single center. AJR Am J Roentgenol. 2017;208(2):446–452.
Torres A, Koskinen SK, Gjertsen H, et al. Contrast-enhanced ultrasound using sulfur hexafluoride is safe in the pediatric setting. Acta Radiol. 2017;58(11):1395–1399.
Piskunowicz M, Kosiak W, Batko T, et al. Safety of intravenous application of second-generation ultrasound contrast agent in children: prospective analysis. Ultrasound Med Biol. 2015;41(4):1095–1099.
Jacob J, Deganello A, Sellars ME, et al. Contrast enhanced ultrasound (CEUS) characterization of grey-scale sonographic indeterminate focal liver lesions in pediatric practice. Ultraschall Med. 2013;34(6):529–540.
Anupindi SA, Biko DM, Ntoulia A, et al. Contrast-enhanced US assessment of focal liver lesions in children. Radiographics. 2017;37(6):1632–1647.
Rosado E, Riccabona M. Off-label use of ultrasound contrast agents for intravenous applications in children: analysis of the existing literature. J Ultrasound Med. 2016;35(3):487–496.
Bonini G, Pezzotta G, Morzenti C, et al. Contrast-enhanced ultrasound with SonoVue in the evaluation of postoperative complications in pediatric liver transplant recipients. J Ultrasound. 2007;10(2):99–106.
Kramer MR, Bhagat N, Back SJ, et al. Influence of contrast-enhanced ultrasound administration setups on microbubble enhancement: a focus on pediatric applications. Pediatr Radiol. 2018;48(1):101–108.
Zerin JM, Shulkin BL. Postprocedural symptoms in children who undergo imaging studies of the urinary tract: is it the contrast material or the catheter?Radiology. 1992;182(3):727–730.
Papadopoulou F, Ntoulia A, Siomou E, et al. Contrast-enhanced voiding urosonography with intravesical administration of a second-generation ultrasound contrast agent for diagnosis of vesicoureteral reflux: prospective evaluation of contrast safety in 1,010 children. Pediatr Radiol. 2014;44(6):719–728.
K, P.F.E.E.R.M.N.A.D Contrast-enhanced voiding urosonography for diagnosis of vesicoureteric reflux in comparison to conventional methods: a meta-analysis. Vienna, Austria: in ECR Book of Abstracts; 2012.
Papadopoulou F, Anthopoulou A, Siomou E, et al. Harmonic voiding urosonography with a second-generation contrast agent for the diagnosis of vesicoureteral reflux. Pediatr Radiol. 2009;39(3):239–244.
Kis E, Nyitrai A, Várkonyi I, et al. Voiding urosonography with second-generation contrast agent versus voiding cystourethrography. Pediatr Nephrol. 2010;25(11):2289–2293.
Ključevšek D, Battelino N, Tomažič M, et al. A comparison of echo-enhanced voiding urosonography with X-ray voiding cystourethrography in the first year of life. Acta Paediatr. 2012;101(5):e235–e239.
Duran C, del Riego J, Riera L, et al. Voiding urosonography including urethrosonography: high-quality examinations with an optimised procedure using a second-generation US contrast agent. Pediatr Radiol. 2012;42(6):660–667.
Berrocal T, Gayá F, Arjonilla A. Vesicoureteral reflux: can the urethra be adequately assessed by using contrast-enhanced voiding US of the bladder?Radiology. 2005;234(1):235–241.
Duran C, Beltrán VP, González A, et al. Contrast-enhanced voiding urosonography for vesicoureteral reflux diagnosis in children. Radiographics. 2017;37(6):1854–1869.
Darge K, Troeger J. Vesicoureteral reflux grading in contrast-enhanced voiding urosonography. Eur J Radiol. 2002;43(2):122–128.
Darge K, Bruchelt W, Roessling G, et al. Interaction of normal saline solution with ultrasound contrast medium: significant implication for sonographic diagnosis of vesicoureteral reflux. Eur Radiol. 2003;13(1):213–218.
Veldhoen S, Sauer A, Gassenmaier T, et al. Contrast-enhanced voiding urosonography phantom study: intravenous iodinated and gadolinium-based contrast agents may cause false-negative results in assessment of vesicoureteral reflux in children. Pediatr Radiol. 2015;45(6):862–871.
Deganello A, Rafailidis V, Sellars ME, et al. Intravenous and intracavitary use of contrast-enhanced ultrasound in the evaluation and management of complicated pediatric pneumonia. J Ultrasound Med. 2017;36(9):1943–1954.
Lu C, Merrill C, Medellin A, et al. Bowel ultrasound state of the art: grayscale and Doppler ultrasound, contrast enhancement, and elastography in Crohn disease. J Ultrasound Med. 2019;38(2):271–288.
Kljucevsek D, Vidmar D, Urlep D, et al. Dynamic contrast-enhanced ultrasound of the bowel wall with quantitative assessment of Crohn's disease activity in childhood. Radiol Oncol. 2016;50(4):347–354.
Lassau N, Bonastre J, Kind M, et al. Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the French multicenter support for innovative and expensive techniques study. Invest Radiol. 2014;49(12):794–800.
McCarville MB, Coleman JL, Guo J, et al. Use of quantitative dynamic contrast-enhanced ultrasound to assess response to antiangiogenic therapy in children and adolescents with solid malignancies: a pilot study. AJR Am J Roentgenol. 2016;206(5):933–939.
Hudson JM, Williams R, Tremblay-Darveau C, et al. Dynamic contrast enhanced ultrasound for therapy monitoring. Eur J Radiol. 2015;84(9):1650–1657.
Lentacker I, De Smedt S, Sanders NN. Drug loaded microbubble design for ultrasound triggered delivery. Soft Matter. 2009;5(11):2161–2170.
Overgaard J. The current and potential role of hyperthermia in radiotherapy. Int J Radiat Oncol Biol Phys. 1989;16(3):535–549.
Bzyl J, Lederle W, Rix A, et al. Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38). Eur Radiol. 2011;21(9):1988–1995.
Pysz MA, Foygel K, Rosenberg J, et al. Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55). Radiology. 2010;256(2):519–527.
Sugimoto K, Moriyasu F, Negishi Y, et al. Quantification in molecular ultrasound imaging: a comparative study in mice between healthy liver and a human hepatocellular carcinoma xenograft. J Ultrasound Med. 2012;31(12):1909–1916.
Tardy I, Pochon S, Theraulaz M, et al. Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55. Invest Radiol. 2010;45(10):573–578.
Abou-Elkacem L, Bachawal SV, Willmann JK. Ultrasound molecular imaging: moving toward clinical translation. Eur J Radiol. 2015;84(9):1685–1693.
Delalande A, Kotopoulis S, Postema M, et al. Sonoporation: mechanistic insights and ongoing challenges for gene transfer. Gene. 2013;525(2):191–199.
Tomizawa M, Shinozaki F, Motoyoshi Y, et al. Sonoporation: gene transfer using ultrasound. World J Methodol. 2013;3(4):39–44.
Dimcevski G, Kotopoulis S, Bjånes T, et al. A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer. J Control Release. 2016;243:172–181.
Huang Y, Alkins R, Schwartz ML, et al. Opening the blood-brain barrier with MR imaging-guided focused ultrasound: preclinical testing on a trans-human skull porcine model. Radiology. 2017;282(1):123–130.
O'Reilly MA, Waspe AC, Chopra R, et al. MRI-guided disruption of the blood-brain barrier using transcranial focused ultrasound in a rat model. J Vis Exp. 2012;(61):3555.
Deshpande N, Needles A, Willmann JK. Molecular ultrasound imaging: current status and future directions. Clin Radiol. 2010;65(7):567–581.
Zhou Y. Principles and Applications of Therapeutic Ultrasound in Healthcare. 1st ed. Boca Raton, FL: CRC Press; 2015.